Discussing New FDA Leadership, Food Safety, and New Developments in mRNA...
Senior Fellow Scott Gottlieb discusses new FDA leadership, food safety, and new developments in mRNA cancer therapy on CBS’ ‘Face the Nation.’ The post Discussing New FDA Leadership, Food Safety, and...
View ArticleDiscussing President Trump’s executive order on the childhood vaccine...
Senior Fellow Scott Gottlieb discusses President Trump’s executive order on the childhood vaccine schedule and concerns over food safety on CNBC’s ‘Squawk Box.’ The post Discussing President Trump’s...
View ArticleDiscussing the latest developments in the Cyclospora outbreak: Gottlieb on...
Senior Fellow Scott Gottlieb discusses the latest developments in the Cyclospora outbreak on CNBC’s ‘Squawk Box.’ The post Discussing the latest developments in the Cyclospora outbreak: Gottlieb on...
View ArticleDiscussing the federal response to the Cyclospora outbreak, rising measles...
Senior Fellow Scott Gottlieb discusses the federal response to the Cyclospora outbreak, rising measles cases, and the risks of compounded peptides on CBS’ ‘Face the Nation.’ The post Discussing the...
View ArticleDiscussing the FDA’s probe into the Cyclospora outbreak: Gottlieb on MS Now’s...
Senior Fellow Scott Gottlieb discusses the FDA’s probe into the Cyclospora outbreak on MS Now’s ‘Money, Power, Politics with Stephanie Ruhle.’ The post Discussing the FDA’s probe into the Cyclospora...
View ArticleDiscussing the Cyclospora outbreak, the FDA’s response, and steps consumers...
Senior Fellow Scott Gottlieb discusses the Cyclospora outbreak linked to bagged lettuce, the FDA’s response, and steps consumers can take to reduce their risk on CNBC’s ‘Squawk Box.’ The post...
View ArticleDiscussing concerns over the shift of drug trials to China and the FDA’s new...
Senior Fellow Scott Gottlieb discusses concerns over the shift of drug trials to China and the FDA’s new PreCheck program on CNBC’s ‘Squawk Box.’ The post Discussing concerns over the shift of drug...
View ArticleDiscussing where the FDA is headed: Gottlieb on CNBC’s ‘Squawk Box’
Senior Fellow Scott Gottlieb discusses where the FDA is headed on CNBC’s ‘Squawk Box.’ The post Discussing where the FDA is headed: Gottlieb on CNBC’s ‘Squawk Box’ appeared first on American...
View ArticleDiscussing the latest developments in the Ebola outbreak and FDA management...
Senior Fellow Scott Gottlieb discusses the latest developments in the Ebola outbreak in West Africa and FDA management changes on CNBC’s ‘Squawk Box.’ The post Discussing the latest developments in...
View ArticleClik here to view.
AI Needs a Report Card, Not a Washington Permission Slip
My fellow pro-growth/progress/abundance Up Wingers in America and around the world: At this point in the 42nd month of the generative AI era, I think it’s unimportant—from a public policy...
View ArticleDiscussing recent changes at the FDA and what comes next: Gottlieb on NPR’s...
Senior Fellow Scott Gottlieb discusses recent changes at the FDA and what comes next for the agency on NPR’s ‘Morning Edition.’ The post Discussing recent changes at the FDA and what comes next:...
View ArticleDiscussing the latest on the hantavirus outbreak and the FDA’s updated...
Senior Fellow Scott Gottlieb discusses the latest on the hantavirus outbreak, developments at the FDA, and the agency’s updated policies on vaping devices on CNBC’s ‘Squawk Box.’ The post Discussing...
View ArticleDiscussing the hantavirus outbreak and public health preparedness: Gottlieb...
Senior Fellow Scott Gottlieb discusses the hantavirus outbreak, public health preparedness, and why experts say the overall risk to Americans remains low on CBS’ ‘Face the Nation.’ The post Discussing...
View ArticleTrump’s executive order on psychedelics strikes a healthy balance
A growing body of evidence indicates psychedelics can help treat serious conditions such as treatment-resistant depression and post-traumatic stress disorder, even as some advocates of these therapies...
View ArticleDiscussing the rapid expansion of CAR-T therapies and efforts to streamline...
Senior Fellow Scott Gottlieb discusses the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments...
View ArticleDiscussing the FDA’s new rare disease framework: Gottlieb on CNBC’s ‘Squawk Box’
Senior Fellow Scott Gottlieb discusses the FDA’s new rare disease framework on CNBC’s ‘Squawk Box.’ The post Discussing the FDA’s new rare disease framework: Gottlieb on CNBC’s ‘Squawk Box’ appeared...
View ArticleFDA’s Promising New Framework for Rare Genetic Diseases
The ability to treat the underlying causes of rare genetic diseases is a new scientific achievement after many years when gene therapy had remained more aspirational than therapeutic arsenal. In 2017,...
View ArticleClik here to view.
Cannabis-Use Warning Shortcomings by State
This is an update of a report originally published on November 13, 2025. Key Points The combination of increased use and collateral health effects of recreational marijuana raises the question how...
View ArticleDiscussing gridlock at the FDA: Gottlieb at CNBC’s Cures Event
Senior Fellow Scott Gottlieb discusses how to unlock the gridlock at the FDA at CNBC’s Cures Event. The post Discussing gridlock at the FDA: Gottlieb at CNBC’s Cures Event appeared first on American...
View ArticleClik here to view.
The FDA’s Moderna mRNA Reversal
My fellow pro-growth/progress/abundance Up Wingers in the USA and around the world: As Conservative Futurist book readers know, I date the start of Up Wing 1.0—America’s lengthy postwar, pro-progress...
View Article![BLACKPINK – DEADLINE – EP [iTunes Plus M4A]](http://is1-ssl.mzstatic.com/image/thumb/Video211/v4/de/b3/b1/deb3b1d4-ba28-22e8-2428-ef97617b2a4b/90d54d743002a6d66308f217cd867947_Preview_Image_Intermediate_nonvideo_sdr_426725135_2574858051.png/316x316bb.webp)
